Filed: 5/15/2025ACC: 0001104659-25-049266
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 62 equity positions with a total reported market value of $1.53B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
62
Positions
$1.53B
Total AUM (reported)
63.17M
Total Shares
Allocation by class
COM$1.15B75.0%
UNIT SER 1$82.06M5.4%
SHS$76.30M5.0%
RUSSELL 2000 ETF$69.82M4.6%
CL A$67.11M4.4%
SHS USD$63.32M4.1%
COM PAR $.01$23.21M1.5%
Portfolio Concentration
Top 3$412.43M26.9%
4–10$417.79M27.3%
11–25$408.79M26.7%
Rest$292.12M19.1%
Top 3 weight
26.9%
Top 10 weight
54.2%
Voting Authority Distribution
Total shares with voting rights: 63.17M
Sole
Full voting authority
63.17M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole62
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings62
Rows:
Natera Inc
SOLEShares1.55M
TypeSH
Market value$219.23M
14.32%
Sole
1.55M
Shared
0.00
None
0.00
Stryker Corporation
SOLEShares298.57K
TypeSH
Market value$111.14M
7.26%
Sole
298.57K
Shared
0.00
None
0.00
Invesco QQQ TR
SOLEShares175K
TypeSH
Market value$82.06M
5.36%
Sole
175K
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares1.01M
TypeSH
Market value$72.43M
4.73%
Sole
1.01M
Shared
0.00
None
0.00
iShares TR
SOLEShares350K
TypeSH
Market value$69.82M
4.56%
Sole
350K
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares2.79M
TypeSH
Market value$67.11M
4.38%
Sole
2.79M
Shared
0.00
None
0.00
Jazz Pharmaceuticals PLC
SOLEShares510.05K
TypeSH
Market value$63.32M
4.14%
Sole
510.05K
Shared
0.00
None
0.00
Medtronic PLC
SOLEShares562.99K
TypeSH
Market value$50.59M
3.30%
Sole
562.99K
Shared
0.00
None
0.00
Alnylam Pharmaceuticals Inc
SOLEShares176.18K
TypeSH
Market value$47.57M
3.11%
Sole
176.18K
Shared
0.00
None
0.00
Gilead Sciences Inc
SOLEShares418.90K
TypeSH
Market value$46.94M
3.07%
Sole
418.90K
Shared
0.00
None
0.00
Eli Lilly & Co
SOLEShares52.80K
TypeSH
Market value$43.61M
2.85%
Sole
52.80K
Shared
0.00
None
0.00
IDEAYA Biosciences Inc
SOLEShares2.62M
TypeSH
Market value$42.95M
2.81%
Sole
2.62M
Shared
0.00
None
0.00
Arrivent BioPharma Inc
SOLEShares1.70M
TypeSH
Market value$31.37M
2.05%
Sole
1.70M
Shared
0.00
None
0.00
PTC Therapeutics Inc
SOLEShares579.34K
TypeSH
Market value$29.52M
1.93%
Sole
579.34K
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares2.28M
TypeSH
Market value$27.95M
1.83%
Sole
2.28M
Shared
0.00
None
0.00
Dexcom Inc
SOLEShares395.98K
TypeSH
Market value$27.04M
1.77%
Sole
395.98K
Shared
0.00
None
0.00
BridgeBio Pharma Inc
SOLEShares734.23K
TypeSH
Market value$25.38M
1.66%
Sole
734.23K
Shared
0.00
None
0.00
Replimune Group Inc
SOLEShares2.48M
TypeSH
Market value$24.18M
1.58%
Sole
2.48M
Shared
0.00
None
0.00
Rhythm Pharmaceuticals
SOLEShares446.84K
TypeSH
Market value$23.67M
1.55%
Sole
446.84K
Shared
0.00
None
0.00
Insmed Inc
SOLEShares304.25K
TypeSH
Market value$23.21M
1.52%
Sole
304.25K
Shared
0.00
None
0.00
Blueprint Medicines Corp
SOLEShares261.04K
TypeSH
Market value$23.10M
1.51%
Sole
261.04K
Shared
0.00
None
0.00
Bristol-Myers Squibb Co
SOLEShares371.50K
TypeSH
Market value$22.66M
1.48%
Sole
371.50K
Shared
0.00
None
0.00
Incyte Corp
SOLEShares357.80K
TypeSH
Market value$21.66M
1.41%
Sole
357.80K
Shared
0.00
None
0.00
AnaptysBio Inc
SOLEShares1.16M
TypeSH
Market value$21.57M
1.41%
Sole
1.16M
Shared
0.00
None
0.00
Sarepta Therapeutics Inc
SOLEShares327.62K
TypeSH
Market value$20.91M
1.37%
Sole
327.62K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Natera IncSOLE | COM | 1.55M | SH | $219.23M 14.32% | 1.55M | 0.00 | 0.00 |
Stryker CorporationSOLE | COM | 298.57K | SH | $111.14M 7.26% | 298.57K | 0.00 | 0.00 |
Invesco QQQ TRSOLE | UNIT SER 1 | 175K | SH | $82.06M 5.36% | 175K | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | COM | 1.01M | SH | $72.43M 4.73% | 1.01M | 0.00 | 0.00 |
iShares TRSOLE | RUSSELL 2000 ETF | 350K | SH | $69.82M 4.56% | 350K | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 2.79M | SH | $67.11M 4.38% | 2.79M | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCSOLE | SHS USD | 510.05K | SH | $63.32M 4.14% | 510.05K | 0.00 | 0.00 |
Medtronic PLCSOLE | SHS | 562.99K | SH | $50.59M 3.30% | 562.99K | 0.00 | 0.00 |
Alnylam Pharmaceuticals IncSOLE | COM | 176.18K | SH | $47.57M 3.11% | 176.18K | 0.00 | 0.00 |
Gilead Sciences IncSOLE | COM | 418.90K | SH | $46.94M 3.07% | 418.90K | 0.00 | 0.00 |
Eli Lilly & CoSOLE | COM | 52.80K | SH | $43.61M 2.85% | 52.80K | 0.00 | 0.00 |
IDEAYA Biosciences IncSOLE | COM | 2.62M | SH | $42.95M 2.81% | 2.62M | 0.00 | 0.00 |
Arrivent BioPharma IncSOLE | COM | 1.70M | SH | $31.37M 2.05% | 1.70M | 0.00 | 0.00 |
PTC Therapeutics IncSOLE | COM | 579.34K | SH | $29.52M 1.93% | 579.34K | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 2.28M | SH | $27.95M 1.83% | 2.28M | 0.00 | 0.00 |
Dexcom IncSOLE | COM | 395.98K | SH | $27.04M 1.77% | 395.98K | 0.00 | 0.00 |
BridgeBio Pharma IncSOLE | COM | 734.23K | SH | $25.38M 1.66% | 734.23K | 0.00 | 0.00 |
Replimune Group IncSOLE | COM | 2.48M | SH | $24.18M 1.58% | 2.48M | 0.00 | 0.00 |
Rhythm PharmaceuticalsSOLE | COM | 446.84K | SH | $23.67M 1.55% | 446.84K | 0.00 | 0.00 |
Insmed IncSOLE | COM PAR $.01 | 304.25K | SH | $23.21M 1.52% | 304.25K | 0.00 | 0.00 |
Blueprint Medicines CorpSOLE | COM | 261.04K | SH | $23.10M 1.51% | 261.04K | 0.00 | 0.00 |
Bristol-Myers Squibb CoSOLE | COM | 371.50K | SH | $22.66M 1.48% | 371.50K | 0.00 | 0.00 |
Incyte CorpSOLE | COM | 357.80K | SH | $21.66M 1.41% | 357.80K | 0.00 | 0.00 |
AnaptysBio IncSOLE | COM | 1.16M | SH | $21.57M 1.41% | 1.16M | 0.00 | 0.00 |
Sarepta Therapeutics IncSOLE | COM | 327.62K | SH | $20.91M 1.37% | 327.62K | 0.00 | 0.00 |
Page 1 of 3